Cargando…
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
OBJECTIVE: It is unclear if activation of inflammatory pathways regulates proprotein convertase subtilisin-kexin type 9 (PCSK9) levels. APPROACH: We evaluated (1) the temporal course of serum PCSK9 during hospitalisation following acute coronary syndrome and associations with markers of inflammation...
Autores principales: | Ueland, Thor, Kleveland, Ola, Michelsen, Annika E, Wiseth, Rune, Damås, Jan Kristian, Aukrust, Pål, Gullestad, Lars, Halvorsen, Bente, Yndestad, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150185/ https://www.ncbi.nlm.nih.gov/pubmed/30258647 http://dx.doi.org/10.1136/openhrt-2017-000765 |
Ejemplares similares
-
Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction
por: Helseth, Ragnhild, et al.
Publicado: (2021) -
Novel Insights Into the Effects of Interleukin 6 Antagonism in Non–ST‐Segment–Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform
por: George, Marc J., et al.
Publicado: (2020) -
IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
por: Orrem, Hilde L., et al.
Publicado: (2018) -
Impact of age on excess risk of coronary heart disease in patients with familial hypercholesterolaemia
por: Mundal, Liv J, et al.
Publicado: (2018) -
IL-18 and IL-18 binding protein are related to disease severity and parasitemia during falciparum malaria
por: Otterdal, Kari, et al.
Publicado: (2021)